• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类胎盘中的CD44:定位及与透明质酸的结合

CD44 in human placenta: localization and binding to hyaluronic acid.

作者信息

St Jacques S, Dadi H K, Letarte M

机构信息

Division of Immunology and Cancer Research, Hospital For Sick Children, Toronto, Canada.

出版信息

Placenta. 1993 Jan-Feb;14(1):25-39. doi: 10.1016/s0143-4004(05)80246-2.

DOI:10.1016/s0143-4004(05)80246-2
PMID:8456087
Abstract

CD44, a receptor for hyaluronic acid (HA), has been identified in the stroma of stem and terminal chorionic villi of human term placenta. The CD44 glycoprotein antigen, isolated from placenta by affinity to monoclonal antibody (mAb) 50B4, consisted mainly of species of M(r) 85,000 and 200,000. Radiolabelled CD44 bound specifically to HA attached to plastic, predominantly via the M(r) 85,000 species; this binding was inhibited by soluble HA and hyaluronidase. The binding of CD44 to HA was also inhibited by mAb 50B4 and IM7.8.1, which recognize epitopes of cluster I and II respectively, but was not blocked by a polyclonal antibody to peptide 18-30 of the B loop (residues 12-101). These results suggest that the portion of the B loop of CD44 implicated in the binding to HA is between amino acids 31-101 and that epitopes located outside the B loop, such as that recognized by mAb IM7.8.1 (between residues 132-215), contribute to this interaction. The presence of a functional CD44 molecule in the human term placenta suggest a role for this molecule in situ in the stabilization and orientation of HA network important in the maintenance of the structural integrity of the placenta.

摘要

CD44是一种透明质酸(HA)受体,已在人足月胎盘的干绒毛和终末绒毛基质中被鉴定出来。通过与单克隆抗体(mAb)50B4亲和从胎盘中分离出的CD44糖蛋白抗原,主要由分子量为85,000和200,000的分子组成。放射性标记的CD44特异性结合附着于塑料的HA,主要通过分子量为85,000的分子;这种结合被可溶性HA和透明质酸酶抑制。CD44与HA的结合也被分别识别簇I和簇II表位的mAb 50B4和IM7.8.1抑制,但不被针对B环(第12 - 101位氨基酸)18 - 30肽段的多克隆抗体阻断。这些结果表明,CD44的B环中与HA结合相关的部分在第31 - 101位氨基酸之间,并且位于B环之外的表位,如被mAb IM7.8.1识别的表位(第132 - 215位氨基酸之间),有助于这种相互作用。人足月胎盘中功能性CD44分子的存在表明该分子在维持胎盘结构完整性所必需的HA网络的稳定和定向中发挥原位作用。

相似文献

1
CD44 in human placenta: localization and binding to hyaluronic acid.人类胎盘中的CD44:定位及与透明质酸的结合
Placenta. 1993 Jan-Feb;14(1):25-39. doi: 10.1016/s0143-4004(05)80246-2.
2
Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.佛波醇肉豆蔻酸酯乙酸酯、抗CD44单克隆抗体和多克隆抗体对人CD44H和CD44E同种型与透明质酸结合的调节作用。
J Immunol. 1993 Dec 1;151(11):6490-9.
3
Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes.
Exp Cell Res. 1992 Nov;203(1):80-90. doi: 10.1016/0014-4827(92)90042-7.
4
CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.活化B细胞上的CD44表达。CD44依赖性结合透明质酸的差异能力。
J Immunol. 1993 Dec 15;151(12):6712-22.
5
Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.人淋巴细胞通过CD44与透明质酸的诱导性结合不需要细胞骨架关联,但需要新的蛋白质合成。
J Immunol. 1994 Jan 15;152(2):467-77.
6
Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.针对CD44的单克隆抗体及其对透明质酸识别的影响。
J Cell Biol. 1995 Jul;130(2):485-95. doi: 10.1083/jcb.130.2.485.
7
Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.CD44与透明质酸结合的要求:胞质结构域的作用及抗体激活
J Exp Med. 1992 Jan 1;175(1):257-66. doi: 10.1084/jem.175.1.257.
8
CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.在正常小鼠T细胞中,CD44可被激活以发挥透明质酸受体的功能。
Eur J Immunol. 1992 Oct;22(10):2719-23. doi: 10.1002/eji.1830221036.
9
CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen.CD44参与人类结肠癌细胞与层粘连蛋白和IV型胶原的黏附。
Surg Oncol. 1993 Aug;2(4):255-64. doi: 10.1016/0960-7404(93)90015-q.
10
Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.透明质酸诱导的淋巴细胞信号转导及HA受体(GP85/CD44)-细胞骨架相互作用
J Immunol. 1993 Dec 15;151(12):6634-44.

引用本文的文献

1
Exploratory analysis of differences at the transcriptional interface between the maternal and fetal compartments of the sheep placenta and potential influence of fetal sex.绵羊胎盘母体和胎儿部分转录界面差异的探索性分析及胎儿性别的潜在影响。
Mol Cell Endocrinol. 2025 Jun 1;603:112546. doi: 10.1016/j.mce.2025.112546. Epub 2025 Apr 12.
2
Dysregulation of CD44v6 may lead to recurrent spontaneous abortion by inhibiting the proliferation and migration of trophoblast cells.CD44v6的失调可能通过抑制滋养层细胞的增殖和迁移导致复发性自然流产。
Int J Clin Exp Pathol. 2018 Apr 1;11(4):2072-2079. eCollection 2018.
3
Role of mouse Wdr13 in placental growth; a genetic evidence for lifetime body weight determination by placenta during development.
小鼠Wdr13在胎盘生长中的作用;胎盘在发育过程中决定终生体重的遗传学证据。
Sci Rep. 2015 Aug 26;5:13371. doi: 10.1038/srep13371.
4
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.透明质酸与其受体(CD44、RHAMM)之间的相互作用调节炎症和癌症的活动。
Front Immunol. 2015 May 6;6:201. doi: 10.3389/fimmu.2015.00201. eCollection 2015.
5
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.透明质酸荚膜调节M蛋白介导的黏附,并作为A组链球菌与人角质形成细胞上CD44结合的配体。
J Clin Invest. 1998 Apr 15;101(8):1708-16. doi: 10.1172/JCI2121.
6
Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis.埃兹蛋白寡聚体是胎盘微绒毛的主要细胞骨架成分:关于它们参与皮质形态发生的一项提议。
J Cell Biol. 1995 Dec;131(5):1231-42. doi: 10.1083/jcb.131.5.1231.
7
Isolation and characterisation of a hyaluronan binding protein, hyaluronectin, from human placenta and its colocalisation with hyaluronan.从人胎盘中分离并鉴定一种透明质酸结合蛋白——透明质粘连蛋白,及其与透明质酸的共定位
J Anat. 1995 Feb;186 ( Pt 1)(Pt 1):131-42.